A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer (Q33405622)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer |
scientific article |
Statements
1 reference
A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer (English)
1 reference
Luis Paz-Ares
1 reference
Beatrix Bálint
1 reference
Richard H de Boer
1 reference
Jan P van Meerbeeck
1 reference
Rafal Wierzbicki
1 reference
Paul De Souza
1 reference
Francesco Galimi
1 reference
Vincent Haddad
1 reference
Tony Sabin
1 reference
Yong-jiang Hei
1 reference
Yang Pan
1 reference
Susan Cottrell
1 reference
Cheng-Pang Hsu
1 reference
1 March 2013
1 reference
1 reference
329-337
1 reference
Identifiers
1 reference
1 reference